NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
04/13/2025
Back to search
Official data from USPTO
PHANES THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/14/2025
Trademark type
Combined
Nice classes
42
Filing date
08/03/2017
Registration date
10/02/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/13/2025
Last transaction
04/14/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/01/2017
First use in commerce
09/01/2017
Drawing code
3
Owner type
03
Owner location
SAN DIEGO, CA
Examiner
HELLMAN, ELI
Current location
Historical data usage
Mark description
The mark consists of a human figure whose left hand raising a DNA pattern, the wording "PHANES" which is at the right of the human figure and the wording "THERAPEUTICS" which is at the lower right of "PHANES".
Holders and representatives
Holders
Phanes Therapeutics, Inc.
Representatives
Andrew T. Rissler PATEL & ALMEIDA, P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development services in the field of antibodies; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical and scientific research in the field of cancer treatment and diagnosis; technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; pharmaceutical products development; pharmaceutical product evaluation; development of pharmaceutical preparations and medicines; conducting early evaluations in the field of new pharmaceuticals; medical and scientific researchconducting clinical trials for others; chemicalbiochemicalbiological and bacteriological research and analysis; biological research; scientific study and research in the fields of medicinethe preventiontreatment and management of illnesshealth care delivery; technology research in the field of pharmaceutical research and development; research and development in the field of medicinethe preventiontreatment and management of illnesshealth care delivery; medical research; medical laboratories; medical and scientific research in the field of medicinethe preventiontreatment and management of illnesshealth care delivery
Publications
History of USPTO decisions and trademark events.
30 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
04/13/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/13/2025
ES8R
TEAS SECTION 8 RECEIVED
10/01/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/27/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/27/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
10/02/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/29/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/28/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/28/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/14/2018
IUAF
USE AMENDMENT FILED
07/17/2018
EISU
TEAS STATEMENT OF USE RECEIVED
07/17/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/27/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/02/2018
PUBO
PUBLISHED FOR OPPOSITION
01/02/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/13/2017
ALIE
ASSIGNED TO LIE
11/27/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/15/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/15/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/14/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/14/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/12/2017
GNRT
NON-FINAL ACTION E-MAILED
11/12/2017
CNRT
NON-FINAL ACTION WRITTEN
11/12/2017
DOCK
ASSIGNED TO EXAMINER
11/03/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/10/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/09/2017
NWAP
NEW APPLICATION ENTERED
08/07/2017
Continuous trademark protection
Get notified about every new filing that threatens PHANES THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.